Pharmacovigilance – News and Features

ReNeuron files IND application to commence human clinical studies with ReN001 stem cell therapy for stroke.

InnoMed PredTox is a joint industry, academic and European Commission collaboration to improve drug safety testing.

SR Pharma has announced that studies have demonstrated the therapeutic efficacy of Atu027 RNAi in pre-clinical models of pancreatic cancer.

The technique offers new possibilities for matching drug treatments more closely to patient needs.

DNA tests could prevent thousands of emergency room visits, hospitalizations and deaths for warfarin patients.

The three-year, $1.6 million grant will be used to further develop VisualHeart, a cardiac modeling software platform.

Lead investigator reports preliminary observations of safety and feasibility.

Ambit expects to screen a large library of kinase-focused compounds obtained from Cephalon.

Assays were measured for their reproducibility, signal intensity, and the ability to make genotype calls.

Scientists from Applied Biosystems presented data demonstrating the accuracy of TaqMan® Drug Metabolism Genotyping Assays in identifying variation in genes that code for drug metabolism enzymes.